Ecliptasaponin D

• UNSPSC Description:

  Ecliptasaponin D is a triterpenoid glucoside isolated from Eclipta alba (L.) Hassk which is the aerial part of Eclipta prostrate. Eclipta prostrate is considered as a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant and immunomodulatory[1,2].

• Target Antigen:

  Others

• Type:

  Natural Products

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ecliptasaponin-d.html

• Purity:

  99.28

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  OC([C@]1(CCC(C)(C)C2)[C@]2([H])C3=CC[C@@]4([H])[C@@](C)(CC[C@]5([H])[C@@]4(CC[C@H](O[C@]([C@@H]([C@@H](O)[C@@H]6O)O)([H])O[C@@H]6CO)C5(C)C)C)[C@]3(C)C[C@@H]1O)=O

• Molecular Weight:

  634.84

• References & Citations:

  [1]Zhang M, et al. [Isolation and identification of ecliptasaponin D from Eclipta alba (L.) Hassk]. Yao Xue Xue Bao. 1997 Aug;32(8):633-4.|[2]You XY, et al. Preventive effects of Ecliptae Herba extract and its component, ecliptasaponin A, on bleomycin-induced pulmonary fibrosis in mice. J Ethnopharmacol. 2015 Dec 4;175:172-80.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, protect from light)

• Clinical Information:

  No Development Reported

• CAS Number:

  206756-04-9